Bracco Diagnostic Inc, GENERAL ELECTRIC, Guerbet are dominating the Global Iodinated Contrast Media In Interventional X-Ray Market in 2019

Global Iodinated Contrast Media In Interventional X-Ray Market is expected to grow at a CAGR of 5.3% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-iodinated-contrast-media-in-interventional-x-ray-market

The major players dealing in global iodinated contrast media in interventional X-ray market are introducing strong range of product portfolio. This helped company to maximize the sales with enhanced product portfolio. For instance, In July 2018, General Electric announced that they have launched ready-to-drink oral solution of iodinated contrast agent which can help physicians improving the visualization of diagnostic abdominal gastrointestinal tract. With this new formulation of contrast agent the company enhanced its choice of options for oral contrast agent which is available to radiologists and patients.

Bracco Diagnostic Inc dominates the iodinated contrast media in interventional X-ray market. The other key players existing in the market includes Guerbet, GENERAL ELECTRIC. The other key players existing in the market Bayer AG, Iso-Tex Diagnostics, Inc., Novalek Pharmaceuticals Pvt. Ltd., iMAX, Taejoon Pharm, Unijules Life Sciences Ltd, Guerbet LLC, J.B.Chemicals & Pharmaceuticals Ltd among others.

Bracco Diagnostic Inc

Bracco Diagnostic Inc is headquartered in New Jersey, U.S. was founded in 1994. The company focuses on the manufacturing and commercialization of innovative contrast imaging agents. The company has various product category such as providing CT & CT Colonography, Magnetic Resonance Imaging, Injectors & Informatics, Nuclear Medicine & Radiopharmaceuticals, Cardiac Catheterization and Interventional Radiology, Fluoroscopy, Contrast Enhanced Ultrasound, Myelography. The market focus products category is CT & CT Colonography.

In March 2015, Bracco Diagnostic Inc. announced that the availability of its product EmpowerCTA, which is an advanced contrast injection engineering system used in computed tomography is initially launched in the U.S. and Europe. This new technology of company’s product provides streamline workflow, and also enhanced the safety as well as control at the patient side.

The company has global Presence in North America, South America, Europe, Middle East and Africa, Asia-Pacific.  

GENERAL ELECTRIC  

GENERAL ELECTRIC headquartered in Massachusetts, U.S. was established in 1892. The company is focused world-class engineering with software, manufacturing, materials science and data analytics to deliver high value to customers. The company has multiple business segment power, renewable energy, aviation, oil & gas, healthcare, transportation, lightings, capital. In this healthcare is the market focused segment. The company has various business categories GE Additive, GE aviation, GE capital, GE digital, GE healthcare, GE lighting, GE power, GE renewable energy and GE research. In this GE healthcare is the market focused business. 

In June 2019, General Electric and Daiichi Sankyo Company did an agreement that Daiichi Sankyo to transfer authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After completing this agreement the company expands their diagnostic imaging agents in the Japan.

The company has global Presence in Europe, America, Asia-Pacific, Middle East and Africa. The company has various subsidiaries such as GE Capital or Financial Services (U.S.), GE Healthcare (U.S.), General Electric Capital Corporation or GECC (U.S.), GE Industrial (U.S.), GE Capital Global Holdings, LLC (U.S.),Baker Hughes (U.S.)among others.   

GUERBET 

GUERBET is headquartered in Villepinte, France was founded in 1926.  The company is engaged in manufacturing of contrast agents, medical devices and innovative solutions for diagnostic and interventional imaging. The company has product category of diagnostic imaging, interventional imaging. In this, market focused category is diagnostic imaging, interventional imaging.

In June 2019, Guerbet attended two conferences, Royal College of Obstetricians and Gynaecologists (RCOG) World Congress in London and European Society of Human Reproduction & Embryology (ESHRE) 2019 in Vienna. After attending this type of conferences the company enhances their credibility in the market.

The company has global Presence in Europe, America, Asia-Pacific, Middle East and Africa.  The company has various subsidiaries such as Guerbet LLC (U.S.), Guerbet A.G. (Switzerland), Guerbet Asie Pacifique (Hong Kong), Guerbet S.p.A (Netherlands), Guerbet Austria G.M.B.H (Austria) among others.

Recent Strategic Decisions

Iodinated Contrast Media in Interventional X-Ray Market